Literature DB >> 30194509

A Multi-Fidelity Rollout Algorithm for Dynamic Resource Allocation in Population Disease Management.

Ting-Yu Ho1, Shan Liu2, Zelda B Zabinsky1.   

Abstract

Dynamic resource allocation for prevention, screening, and treatment interventions in population disease management has received much attention in recent years due to excessive healthcare costs. In this paper, our goal is to design a model and an efficient algorithm to optimize sequential intervention policies under resource constraints to improve population health outcomes. We consider a discrete-time finite-horizon budget allocation problem with disease progression within a closed birth-cohort population. To address the computational challenges associated with large-state and multiple-period dynamic decision-making problems, we propose a low-fidelity approximation that preserves the population dynamics under a stationary policy. To improve the healthcare interventions in terms of population health outcomes, we then embed the low-fidelity approximation into a high-fidelity optimization model to efficiently identify a good non-stationary sequential intervention policy. Our approach is illustrated by a numerical example of screening and treatment policy implementation for chronic hepatitis C virus (HCV) infection over a budget planning period. We numerically compare our Multi-Fidelity Rollout Algorithm (MF-RA) to a grid search approach and demonstrate the similarity of sequential policy trends and closeness of overall health outcomes measured by quality-adjusted life-years (QALYs) and the total number of individuals that undergo screening and treatment for different annual budgets and birth-cohorts. We also show how our approach scales well to problems with high dimensionality due to many decision periods by studying time to elimination of HCV.

Entities:  

Keywords:  Dynamic programming; Hepatitis C; Markov processes; Rollout algorithm; Screening and treatment interventions; Simulation

Mesh:

Year:  2018        PMID: 30194509     DOI: 10.1007/s10729-018-9454-6

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  30 in total

1.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

Review 2.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

3.  Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Authors:  Maria Stepanova; Fasiha Kanwal; Hashem B El-Serag; Zobair M Younossi
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

4.  Screening for HCV infection in jails.

Authors:  Anne C Spaulding; David L Thomas
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

5.  Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study.

Authors:  Jennifer R Kramer; Fasiha Kanwal; Peter Richardson; Thomas P Giordano; Laura A Petersen; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2010-11-09       Impact factor: 10.864

6.  Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.

Authors:  Jagpreet Chhatwal; Fasiha Kanwal; Mark S Roberts; Michael A Dunn
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

7.  Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.

Authors:  Tianhua He; Kan Li; Mark S Roberts; Anne C Spaulding; Turgay Ayer; John J Grefenstette; Jagpreet Chhatwal
Journal:  Ann Intern Med       Date:  2015-11-24       Impact factor: 25.391

8.  The natural history of late-life depression: a 6-year prospective study in the community.

Authors:  Aartjan T F Beekman; Sandra W Geerlings; Dorly J H Deeg; Jan H Smit; Robert S Schoevers; Edwin de Beurs; Arjan W Braam; Brenda W J H Penninx; Willem van Tilburg
Journal:  Arch Gen Psychiatry       Date:  2002-07

Review 9.  Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.

Authors:  Oluwaseun Falade-Nwulia; Catalina Suarez-Cuervo; David R Nelson; Michael W Fried; Jodi B Segal; Mark S Sulkowski
Journal:  Ann Intern Med       Date:  2017-03-21       Impact factor: 25.391

10.  The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.

Authors:  Benjamin P Linas; Devra M Barter; Jake R Morgan; Mai T Pho; Jared A Leff; Bruce R Schackman; C Robert Horsburgh; Sabrina A Assoumou; Joshua A Salomon; Milton C Weinstein; Kenneth A Freedberg; Arthur Y Kim
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 51.598

View more
  1 in total

1.  Fair and diverse allocation of scarce resources.

Authors:  Hadis Anahideh; Lulu Kang; Nazanin Nezami
Journal:  Socioecon Plann Sci       Date:  2021-11-13       Impact factor: 4.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.